Packing the donor heart: Is SherpaPak cold preservation technique safer compared to ice cold storage.
SherpaPak
cold storage
heart transplantation
organ preservation
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
27
04
2022
received:
27
11
2021
accepted:
03
05
2022
pubmed:
12
5
2022
medline:
11
8
2022
entrez:
11
5
2022
Statut:
ppublish
Résumé
The present study aimed to compare the clinical outcomes of heart transplant patients whose donor hearts were preserved with the SherpaPak controlled cold organ system versus the conventional ice storage technique. All patients undergoing heart transplantation at our center between January 2019 and April 2021 were divided into two groups according to the technique used during donor heart preservation and transport. The first group consisted of 34 SherpaPak controlled temperature preservation patients, and the second group consisted of 47 patients where the conventional three bags and ice technique was utilized during organ transportation. The two groups were compared based on demographics, operative details, and postoperative outcomes. There were no significant differences between the groups regarding Vasoactive Inotropic Score (VIS), Primary Graft Dysfunction (PGD), and the need for a transient pacer. However, the VIS, PGD, and pacing trends were lower in the SherpaPak patients even though the total ischemic and cardiopulmonary bypass times were significantly longer. Furthermore, SherpaPak patients exhibited a shorter stay in the ICU with no severe PGD and mortality. The SherpaPak donor heart preservation provides safe outcomes in heart transplant patients. Further research is needed to utilize this method for longer durations of ischemic time and expand travel distances for organ transportation.
Substances chimiques
Ice
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14707Informations de copyright
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Pulis RP, Wu BM, Kneteman NM, Churchill TA. Conservation of phosphorylation state of cardiac phosphofructokinase during in vitro hypothermic hypoxia. Am J Physiol Heart Circ Physiol. 2000;279(5):H2151-H2158.
Hendry PJ, Walley VM, Koshal A, Masters RG, Keon WJ. Are temperatures attained by donor hearts during transport too cold. J Thorac Cardiovasc Surg. 1989;98(4):517-522.
Russo MJ, Iribarne A, Hong KN, et al. Factors associated with primary graft failure after heart transplantation. Transplantation. 2010;90(4):444-450.
Copeland H, Hayanga JWA, Neyrinck A, et al. Donor heart and lung procurement: a consensus statement [published correction appears in J Heart Lung Transplant. 2020 Jul;39(7):734]. J Heart Lung Transplant. 2020;39(6):501-517.
Naito N, Funamoto M, Pierson RN, D'Alessandro DA. First clinical use of a novel hypothermic storage system for a long-distance donor heart procurement. J Thorac Cardiovasc Surg. 2020;159(2):e121-e123.
Radakovic D, Karimli S, Penov K, et al. First clinical experience with the novel cold storage SherpaPak™ system for donor heart transportation. J Thorac Dis. 2020;12(12):7227-7235.
https://paragonixtechnologies.com/products/sherpapak-cardiac-organ-transport-system/
Kobashigawa J, Zuckermann A, Macdonald P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart Lung Transplant. 2014;33(4):327-340.
Yamazaki Y, Oba K, Matsui Y, Morimoto Y. Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass. Journal of Anesthesia. 2018;32(2):167-173.
Na SJ, Chung CR, Cho YH, et al. Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO. Rev Esp Cardiol (Engl Ed). 2019;72(1):40-47.
Ardehali A, Esmailian F, Deng M, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;385(9987):2577-2584.
Kon ZN, Smith DE, Carillo JA, Moazami N. Commentary: the future is now-heart donation after circulatory death. J Thorac Cardiovasc Surg. 2021;161(4):1342-1343.
Jahania MS, Sanchez JA, Narayan P, Lasley RD. Heart preservation for transplantation: principles and strategies. Ann Thorac Surg. 1999;68(5):1983-1987.
Horch DF, Mehlitz T, Laurich O, et al. Organ transport temperature box: multicenter study on transport temperature of organs. Transplant Proc. 2002;34(6):2320.
Michel SG, LaMuraglia Ii GM, Madariaga ML, Anderson LM. Innovative cold storage of donor organs using the Paragonix Sherpa Pak ™ devices. Heart Lung Vessel. 2015;7(3):246-255.
Nicoara A, Ruffin D, Cooter M, et al. Primary graft dysfunction after heart transplantation: incidence, trends, and associated risk factors. Am J Transplant. 2018;18(6):1461-1470.
Kilic A, Weiss ES, Arnaoutakis GJ, et al. Identifying recipients at high risk for graft failure after heart retransplantation. Ann Thorac Surg. 2012;93(3):712-716.
Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: multiorgan Transplantation. J Heart Lung Transplant. 2018;37(10):1155-1168.
Gould L, Reddy CV. Effect of cold isotonic glucose infusion on A-V nodal conduction. J Electrocardiol. 1976;9(1):23-28.
Funamoto M, Ong CS, Kilmarx SE, et al. Utilization of new heart preservation technology in the era of new organ allocation and extended ischemic times. J Heart Lung Transplant. 2020;39(4):S136.